Profile of Antibodies to the Nucleocapsid Protein of the Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus in Probable SARS Patients

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical Diagnostic Laboratory Immunology

• Publication date

  2004-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/CDLI.11.1.227-228.2004PMID 14715574PMCID PMC321358
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A novel coronavirus associated with severe acute respiratory syndrome.

  2003cited by this paper
• Profile of specific antibodies to the SARS-associated coronavirus.

  2003cited by this paper
• Personal view of SARS: confusing definition, confusing diagnoses

  2003cited by this paper
• Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

  2003cited by this paper
• Identification of severe acute respiratory syndrome in Canada.

  2003cited by this paper
• Diagnosis of Severe Acute Respiratory Syndrome (SARS) by Detection of SARS Coronavirus Nucleocapsid Antibodies in an Antigen-Capturing Enzyme-Linked Immunosorbent Assay

  2003cited by this paper

• Mixed lipopeptide-based mucosal vaccine candidate induces cross-variant immunity and protects against SARS-CoV-2 infection in hamsters

  2025cites this paper
• Mixed lipopeptide-based mucosal vaccine elicits a long-term bone marrow memory response that is potentially cross-reactive against a broad-spectrum of coronaviruses in mice

  2025cites this paper
• Antibody Responses in SARS-CoV-2-Exposed and/or Vaccinated Individuals Target Conserved Epitopes from Multiple CoV-2 Antigens

  2024influential citation
• Mucosal immunization with lipopeptides derived from conserved regions of SARS-CoV-2 antigens induce robust cellular and cross-variant humoral immune responses in mice

  2023cites this paper
• Construction and Immunogenicity of a Recombinant Pseudorabies Virus Expressing SARS-CoV-2-S and SARS-CoV-2-N

  2022cites this paper
• A comparative study of antibody response, virus neutralization efficiency & metabolites in SARS-CoV-2-infected adults & children

  2022cites this paper
• Predicting COVID-19 Severity with a Specific Nucleocapsid Antibody plus Disease Risk Factor Score

  2021cites this paper
• Serological Profile Of Specific Antibodies Against Dominant Antigens Of SARS-CoV-2 In Chilean COVID-19 Patients.

  2021cites this paper
• Serological assays and host antibody detection in coronavirus-related disease diagnosis

  2021cites this paper
• Whole proteome screening and identification of potential epitopes of SARS-CoV-2 for vaccine design-an immunoinformatic, molecular docking and molecular dynamics simulation accelerated robust strategy

  2021cites this paper
• Harnessing immunological targets for COVID-19 immunotherapy

  2021cites this paper
• The Development of Vaccines against SARS-Cov-2 Virus. An Overview

  2021cites this paper
• Challenges and prospects of COVID‐19 vaccine development based on the progress made in SARS and MERS vaccine development

  2020cites this paper
• Common low complexity regions for SARS-CoV-2 and human proteomes as potential multidirectional risk factor in vaccine development

  2020cites this paper
• Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes

  2020cites this paper
• Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

  2020cites this paper
• Human coronaviruses

  2020cites this paper
• Preliminary identification of potential vaccine targets for 2019-nCoV based on SARS-CoV immunological studies

  2020cites this paper
• Investigation of physical and mental health in isolated people during the outbreak of novel corona virus pneumonia

  2020cites this paper
• Cross-reaction of Sera from COVID-19 Patients with SARS-CoV Assays

  2020cites this paper
• Comparative Analysis of Antigen-Specific Anti–SARS-CoV-2 Antibody Isotypes in COVID-19 Patients

  2020cites this paper
• A review of COVID‐19 vaccines and major considerations for diabetic patients

  2020cites this paper
• An overview on advantages and limitations of serological assays for saRs-coV-2 infectious disease

  2020cites this paper
• Antigenic properties of sARs-CoV-2/human/RUs/nsk-FRCFtM-1/2020 coronavirus isolate from a patient in novosibirsk

  2020cites this paper
• Antibody Response to a Nucleocapsid Epitope as a Marker for COVID-19 Disease Severity

  2020cites this paper
• The possible role of novel coronavirus 2019 proteins in the development of drugs and vaccines

  2020cites this paper
• Immune Response to COVID-19: Can We Benefit from the SARS-CoV and MERS-CoV Pandemic Experience?

  2020cites this paper
• Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study

  2020cites this paper
• Sequence-based prediction of vaccine targets for inducing T cell responses to SARS-CoV-2 utilizing the bioinformatics predictor RECON

  2020cites this paper
• Benefits and limitations of serological assays in COVID-19 infection

  2020cites this paper
• Cross-reaction of sera from COVID-19 patients with SARS-CoV assays.

  2020cites this paper
• Human Coronaviruses

  2017cites this paper
• Serological assays for emerging coronaviruses: Challenges and pitfalls

  2014cites this paper
• Human Coronaviruses

  2013cites this paper
• Genetic Variation of the Human α-2-Heremans-Schmid Glycoprotein (AHSG) Gene Associated with the Risk of SARS-CoV Infection

  2011cites this paper
• Lack of association between polymorphisms of MASP2 and susceptibility to SARS coronavirus infection

  2009cites this paper
• SARS vaccines: where are we?

  2009cites this paper
• Novel Non-SARS Coronaviruses

  2008cites this paper
• Sensitive and Specific Enzyme-Linked Immunosorbent Assay Using Chemiluminescence for Detection of Severe Acute Respiratory Syndrome Viral Infection (cid:1)

  2007cites this paper
• Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen.

  2007influential citation
• , Ping Respiratory Syndrome Coronavirus Nucleocapsid Protein of Severe Acute Dominant Helper T-Cell Epitopes in the Identification and Characterization of

  2007cites this paper
• Comparison of Immunoglobulin G Responses to the Spike and Nucleocapsid Proteins of Severe Acute Respiratory Syndrome (SARS) Coronavirus in Patients with SARS

  2007cites this paper
• Recombinant Protein-Based Assays for Detection of Antibodies to Severe Acute Respiratory Syndrome Coronavirus Spike and Nucleocapsid Proteins

  2007cites this paper
• Formalin-treated UV-inactivated SARS coronavirus vaccine retains its immunogenicity and promotes Th2-type immune responses.

  2007cites this paper
• Sensitive and Specific Enzyme-Linked Immunosorbent Assay Using Chemiluminescence for Detection of Severe Acute Respiratory Syndrome Viral Infection

  2007cites this paper
• The Molecular Biology of SARS Coronavirus

  2007cites this paper
• Analysis of proteins that interact with nucleocapsid protein of SARS-CoV using 15-mer phage-displayed library

  2007cites this paper
• Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.

  2006cites this paper
• Amino terminus of the SARS coronavirus protein 3a elicits strong, potentially protective humoral responses in infected patients.

  2006cites this paper
• Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine

  2006cites this paper
• Identification of a B-cell antigenic epitope at the N-terminus of SARS-CoV M protein and characterization of monoclonal antibody against the protein

  2006cites this paper
• Recombinant protein‐based ELISA and immuno‐cytochemical assay for the diagnosis of SARS†

  2005cites this paper
• Double-antigen sandwich ELISA for detection of antibodies to SARS-associated coronavirus in human serum

  2005cites this paper
• Antigenicity and Immunogenicity of SARS-CoV

  2005cites this paper
• Rapid Response Research - SARS Coronavirus Vaccines and Application of Processes to Other Emerging Infectious Diseases

  2005cites this paper
• Identification of Immunodominant Epitopes on the Membrane Protein of the Severe Acute Respiratory Syndrome-Associated Coronavirus

  2005cites this paper
• Profiles of IgG Antibodies to Nucleocapsid and Spike Proteins of the SARS-Associated Coronavirus in SARS Patients

  2005cites this paper
• Cross-reactivity of antibody against SARS-coronavirus nucleocapsid protein with IL-11

  2005cites this paper
• Interpreting serological studies on severe acute respiratory syndrome: defining the reference.

  2005cites this paper
• Comprehensive Antibody Epitope Mapping of the Nucleocapsid Protein of Severe Acute Respiratory Syndrome (SARS) Coronavirus: Insight into the Humoral Immunity of SARS

  2005cites this paper
• Expression of SARS-coronavirus nucleocapsid protein in Escherichia coli and Lactococcus lactis for serodiagnosis and mucosal vaccination

  2005cites this paper
• Biochemical and immunological studies of nucleocapsid proteins of severe acute respiratory syndrome and 229E human coronaviruses

  2005cites this paper
• A serological survey on neutralizing antibody titer of SARS convalescent sera

  2005cites this paper
• B-Cell Responses in Patients Who Have Recovered from Severe Acute Respiratory Syndrome Target a Dominant Site in the S2 Domain of the Surface Spike Glycoprotein

  2005cites this paper
• Severe acute respiratory syndrome: vaccine on the way.

  2005cites this paper
• Use of the COOH Portion of the Nucleocapsid Protein in an Antigen-Capturing Enzyme-Linked Immunosorbent Assay for Specific and Sensitive Detection of Severe Acute Respiratory Syndrome Coronavirus

  2005cites this paper
• Molecular and Biological Characterization of Human Monoclonal Antibodies Binding to the Spike and Nucleocapsid Proteins of Severe Acute Respiratory Syndrome Coronavirus

  2005cites this paper
• Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals

  2005cites this paper
• Detection of antibodies against SARS-CoV in serum from SARS-infected donors with ELISA and Western blot

  2004cites this paper
• A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice

  2004cites this paper
• Mapping of Antigenic Sites on the Nucleocapsid Protein of the Severe Acute Respiratory Syndrome Coronavirus

  2004cites this paper
• Evaluation of a recombinant nucleocapsid protein‐based assay for Anti‐SARS‐CoV IgG detection

  2004cites this paper
• Expression, Purification and Sublocalization of SARS-CoV Nucleocapsid Protein in Insect Cells

  2004cites this paper
• Rapid response research to emerging infectious diseases: lessons from SARS

  2004cites this paper
• Prediction of class I T-cell epitopes: evidence of presence of immunological hot spots inside antigens

  2004cites this paper
• Use of Viral Lysate Antigen Combined with Recombinant Protein in Western Immunoblot Assay as Confirmatory Test for Serodiagnosis of Severe Acute Respiratory Syndrome

  2004cites this paper